//
Chiara Rusconi
Francesca Ricci
Vincenzo Marasco
Vittorio Ruggero Zilioli
Eleonora Calabretta
Anna Guidetti
Cristina Muzi
Federico Mazzon
Margherita Smania
Martina Sollini
Sara Iadecola
Erika Meli
Marcello Rodari
Emanuele Ravano
Roberto Cairoli
Paolo Corradini
Armando Santoro
Hematology and Bone Marrow Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy
Department of Biomedical Sciences, Humanitas University, Milan, Italy
Università di Milano, MIlano, Italy
Hematology, Humanitas Cancer Center, Istituto Clinico Humanitas, Rozzano, Italy
Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
Department of Oncology and Hematology, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Italy
ASST Grande Ospedale Metropolitano Niguarda, Niguarda Cancer Center, Department of Hematology, MILANO, Italy
Unit of Clinical Epidemiology and Trial Organization, Department of Applied Rese, Milan, ITA
ASST Grande Ospedale Metropolitano Niguarda, Milan, ITA
Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
Department of Nuclear Medicine, Humanitas Clinical and Reseach Center IRCCS, Rozzano, Italy
Nuclear Medicine, IRCCS Humanitas Research Hospital, Milano, Italy
Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
Italy
N/A
Oncology (ONC)
Hodgkin's Lymphoma
N/A
brentuximab vedotin
Adcetris
Bendamustine
Gemcitabine
Vinorelbine
Sandolase
N/A
N/A
NA
N/A
N/A
N/A